These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7351629)

  • 1. Clearance of 5-hydroxytryptamine by rat lung and liver: the importance of relative perfusion and intrinsic clearance.
    Wiersma DA; Roth RA
    J Pharmacol Exp Ther; 1980 Jan; 212(1):97-102. PubMed ID: 7351629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prediction of benzo[a]pyrene clearance by rat liver and lung from enzyme kinetic data.
    Wiersma DA; Roth RA
    Mol Pharmacol; 1983 Sep; 24(2):300-8. PubMed ID: 6310365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prolonged desmethylimipramine administration on the pulmonary clearance of 5-hydroxytryptamine and beta-phenylethylamine in rats.
    Minchin RF; Barber HE; Ilett KF
    Drug Metab Dispos; 1982; 10(4):356-60. PubMed ID: 6126334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance of benzo(a)pyrene by isolated rat liver and lung: alterations in perfusion and metabolic capacity.
    Wiersma DA; Roth RA
    J Pharmacol Exp Ther; 1983 Apr; 225(1):121-5. PubMed ID: 6300370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemistry, physiology and drug metabolism--implications regarding the role of the lungs in drug disposition.
    Roth RA
    Clin Physiol Biochem; 1985; 3(2-3):66-79. PubMed ID: 3891197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroid metabolism in isolated perfused rat liver and kidney. Experimental studies with emphasis on aldosterone.
    Egfjord M
    Acta Physiol Scand Suppl; 1995; 627():1-42. PubMed ID: 8848946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary disposition and effects of drugs on pulmonary removal of endogenous substances.
    Mehendale HM
    Fed Proc; 1984 Aug; 43(11):2586-91. PubMed ID: 6204891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance.
    Rane A; Wilkinson GR; Shand DG
    J Pharmacol Exp Ther; 1977 Feb; 200(2):420-4. PubMed ID: 839445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of flow on first-pass metabolism of drugs: single pass studies on 4-methylumbelliferone conjugation in the serially perfused rat intestine and liver preparations.
    Chen J; Pang KS
    J Pharmacol Exp Ther; 1997 Jan; 280(1):24-31. PubMed ID: 8996177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
    Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic enzyme activity is the major factor determining elimination rate of high-clearance drugs in cirrhosis.
    Callaghan R; Desmond PV; Paull P; Mashford ML
    Hepatology; 1993 Jul; 18(1):54-60. PubMed ID: 8325621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired elimination of propranolol due to right heart failure: drug clearance in the isolated liver and its relationship to intrinsic metabolic capacity.
    Ng CY; Ghabrial H; Morgan DJ; Ching MS; Smallwood RA; Angus PW
    Drug Metab Dispos; 2000 Oct; 28(10):1217-21. PubMed ID: 10997943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clearance by the liver in cirrhosis. I. Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat.
    Fenyves D; Gariépy L; Villeneuve JP
    Hepatology; 1993 Feb; 17(2):301-6. PubMed ID: 8428728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacodynamics of 5-hydroxytryptamine uptake and metabolism by the isolated perfused rabbit lung.
    Pickett RD; Anderson MW; Orton TC; Eling TE
    J Pharmacol Exp Ther; 1975 Sep; 194(3):545-53. PubMed ID: 1159631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xanthine oxidase-induced lung injury inhibits removal of 5-hydroxytryptamine from the pulmonary circulation.
    Cook DR; Howell RE; Gillis CN
    Anesth Analg; 1982 Aug; 61(8):666-70. PubMed ID: 6283949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient extraction by the liver governs overall elimination of hepatocyte growth factor in rats.
    Kato M; Kato Y; Nakamura T; Sugiyama Y
    J Pharmacol Exp Ther; 1999 Jul; 290(1):373-9. PubMed ID: 10381802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the hepatic artery in the metabolism of phenacetin and acetaminophen: intravital microscopic and multiple-indicator dilution study in perfused rat liver.
    Pang KS; Sherman IA; Schwab AJ; Geng W; Barker F; Dlugosz JA; Cuerrier G; Goresky CA
    Hepatology; 1994 Sep; 20(3):672-83. PubMed ID: 8076925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-pass removal of [14C]-5-hydroxytryptamine and [3H]norepinephrine by rabbit lung, in vivo: kinetics and sites of removal.
    Catravas JD; Gillis CN
    J Pharmacol Exp Ther; 1983 Jan; 224(1):28-33. PubMed ID: 6848747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of 5-hydroxytryptamine in lungs of developing rats.
    Wallace KB; Bailie MD; Hook JB; Roth RA
    Am J Physiol; 1980 Nov; 239(5):R401-6. PubMed ID: 7435653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of 5-hydroxytryptamine by rat lungs.
    Osim EE; Wyllie JH
    Acta Physiol Hung; 1991; 78(2):181-9. PubMed ID: 1808984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.